New Ways to Track HPV-Positive Head, Neck Cancer Recurrence
New tests offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow.
Read MorePosted by Andy Lundin | Sep 7, 2023 | Cervical (HPV) |
New tests offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow.
Read MorePosted by Andy Lundin | Aug 31, 2023 | Cancer |
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read MorePosted by Chris Wolski | Aug 21, 2023 | Gastrointestinal Infections |
Diagnostic tests for an H. pylori infection can be invasive or noninvasive. Noninvasive testing is more cost-effective.
Read MorePosted by Andy Lundin | Aug 17, 2023 | Cancer |
Americans have gotten at least 12 million more years of life to live due to preventive cancer screenings conducted over the past 25 years.
Read MorePosted by Andy Lundin | Aug 17, 2023 | Cancer |
The U.S. FDA has granted Tempus Breakthrough Device Designation for its HLA-LOH assay as a companion diagnostic (CDx) test for solid tumors.
Read More